中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/01/18 | 5,821 | 5,858 | 5,751 | 5,751 | -143 | -2.4% | 1,872,500 |
| 2021/01/15 | 5,921 | 6,036 | 5,873 | 5,894 | +92 | +1.6% | 3,015,900 |
| 2021/01/14 | 5,710 | 5,910 | 5,690 | 5,802 | -35 | -0.6% | 2,444,600 |
| 2021/01/13 | 5,802 | 5,880 | 5,691 | 5,837 | -25 | -0.4% | 2,850,200 |
| 2021/01/12 | 6,435 | 6,435 | 5,802 | 5,862 | +327 | +5.9% | 7,881,400 |
| 2021/01/08 | 5,458 | 5,535 | 5,389 | 5,535 | +197 | +3.7% | 2,910,800 |
| 2021/01/07 | 5,319 | 5,380 | 5,287 | 5,338 | +82 | +1.6% | 2,077,000 |
| 2021/01/06 | 5,301 | 5,343 | 5,238 | 5,256 | -71 | -1.3% | 1,695,200 |
| 2021/01/05 | 5,451 | 5,488 | 5,302 | 5,327 | -119 | -2.2% | 1,816,100 |
| 2021/01/04 | 5,411 | 5,519 | 5,410 | 5,446 | -57 | -1% | 1,444,100 |
| 2020/12/30 | 5,505 | 5,549 | 5,481 | 5,503 | +9 | +0.2% | 1,835,600 |
| 2020/12/29 | 5,297 | 5,522 | 5,260 | 5,494 | +88 | +1.6% | 2,030,000 |
| 2020/12/28 | 5,304 | 5,439 | 5,295 | 5,406 | +171 | +3.3% | 1,513,400 |
| 2020/12/25 | 5,345 | 5,352 | 5,224 | 5,235 | -98 | -1.8% | 944,700 |
| 2020/12/24 | 5,205 | 5,370 | 5,205 | 5,333 | +128 | +2.5% | 1,758,200 |
| 2020/12/23 | 5,089 | 5,274 | 5,075 | 5,205 | +171 | +3.4% | 1,994,700 |
| 2020/12/22 | 5,017 | 5,066 | 5,006 | 5,034 | +24 | +0.5% | 1,245,200 |
| 2020/12/21 | 4,993 | 5,027 | 4,912 | 5,010 | +102 | +2.1% | 1,585,000 |
| 2020/12/18 | 4,961 | 4,980 | 4,897 | 4,908 | -53 | -1.1% | 2,120,600 |
| 2020/12/17 | 4,900 | 4,988 | 4,887 | 4,961 | +18 | +0.4% | 1,366,200 |
| 2020/12/16 | 5,027 | 5,043 | 4,904 | 4,943 | -50 | -1% | 1,431,300 |
| 2020/12/15 | 5,070 | 5,076 | 4,971 | 4,993 | -77 | -1.5% | 1,150,500 |
| 2020/12/14 | 5,079 | 5,110 | 5,055 | 5,070 | +19 | +0.4% | 1,069,800 |
| 2020/12/11 | 4,975 | 5,068 | 4,954 | 5,051 | +33 | +0.7% | 2,269,600 |
| 2020/12/10 | 5,000 | 5,044 | 4,963 | 5,018 | -73 | -1.4% | 1,730,300 |
| 2020/12/09 | 5,040 | 5,105 | 5,015 | 5,091 | +146 | +3% | 1,777,800 |
| 2020/12/08 | 5,007 | 5,020 | 4,931 | 4,945 | -93 | -1.8% | 1,861,600 |
| 2020/12/07 | 5,010 | 5,047 | 4,947 | 5,038 | +107 | +2.2% | 1,864,000 |
| 2020/12/04 | 4,896 | 4,950 | 4,881 | 4,931 | -40 | -0.8% | 1,169,800 |
| 2020/12/03 | 4,951 | 5,036 | 4,950 | 4,971 | +25 | +0.5% | 1,565,800 |
| 2020/12/02 | 4,942 | 4,963 | 4,884 | 4,946 | -63 | -1.3% | 2,094,500 |
| 2020/12/01 | 5,070 | 5,143 | 4,961 | 5,009 | -35 | -0.7% | 2,386,900 |
| 2020/11/30 | 4,889 | 5,044 | 4,868 | 5,044 | +193 | +4% | 4,902,300 |
| 2020/11/27 | 4,823 | 4,878 | 4,804 | 4,851 | +48 | +1% | 2,443,700 |
| 2020/11/26 | 4,700 | 4,820 | 4,676 | 4,803 | +134 | +2.9% | 2,055,900 |
| 2020/11/25 | 4,588 | 4,694 | 4,572 | 4,669 | +107 | +2.3% | 2,550,700 |
| 2020/11/24 | 4,506 | 4,583 | 4,485 | 4,562 | +131 | +3% | 2,311,100 |
| 2020/11/20 | 4,548 | 4,564 | 4,424 | 4,431 | -144 | -3.1% | 1,974,500 |
| 2020/11/19 | 4,500 | 4,578 | 4,500 | 4,575 | +50 | +1.1% | 2,530,800 |
| 2020/11/18 | 4,546 | 4,609 | 4,484 | 4,525 | +5 | +0.1% | 1,526,000 |
| 2020/11/17 | 4,582 | 4,600 | 4,472 | 4,520 | -107 | -2.3% | 2,243,000 |
| 2020/11/16 | 4,615 | 4,660 | 4,585 | 4,627 | +43 | +0.9% | 1,841,700 |
| 2020/11/13 | 4,627 | 4,627 | 4,539 | 4,584 | -38 | -0.8% | 2,414,500 |
| 2020/11/12 | 4,662 | 4,680 | 4,590 | 4,622 | -49 | -1% | 2,745,500 |
| 2020/11/11 | 4,607 | 4,704 | 4,580 | 4,671 | +134 | +3% | 2,971,200 |
| 2020/11/10 | 4,595 | 4,600 | 4,504 | 4,537 | +64 | +1.4% | 2,424,400 |
| 2020/11/09 | 4,452 | 4,505 | 4,412 | 4,473 | +44 | +1% | 2,254,400 |
| 2020/11/06 | 4,599 | 4,607 | 4,416 | 4,429 | -183 | -4% | 2,651,000 |
| 2020/11/05 | 4,499 | 4,613 | 4,464 | 4,612 | +298 | +6.9% | 4,201,100 |
| 2020/11/04 | 4,177 | 4,323 | 4,094 | 4,314 | +241 | +5.9% | 2,490,400 |
1051～
1100
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
